CCND2 and diffuse large B-cell lymphoma: We found that, among patients with ABC-DLBCL treated using R-CHOP chemotherapy, relative CCND2 mRNA expression levels were significantly higher in those exhibiting curative control (i.e., complete remission) relative to those who did not achieve complete remission (P = 0.039; Table 3).